Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis

Transplantation

Volumn 64, Issue 5, 1997, Pages 780-782

  Klaassen, Robert J L ^a   Van Gelder, Teun ^a   Rischen Vos, Jacqueline ^a   Deinum, Jaap ^a   Man In't Veld, Arie J ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; POTASSIUM; PREDNISONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTOSIS; HEMATOCRIT; HUMAN; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; POSTOPERATIVE COMPLICATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RECIPIENT; SIDE EFFECT; THROMBOCYTE COUNT;

BIPHENYL COMPOUNDS; ERYTHROCYTE COUNT; HEMATOCRIT; HUMANS; IMIDAZOLES; KIDNEY TRANSPLANTATION; LOSARTAN; PLATELET AGGREGATION INHIBITORS; POLYCYTHEMIA; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0030886126     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709150-00023     Document Type: Article

References (15)

1. Wickre CG, Norman DJ, Bennison A, Barry JM, Bennett WM. Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int 1983; 23: 731.
2. Gaston RS, Julian BA, Curtis JJ. Posttransplant erythrocytosis: an enigma revisited. Am J Kidney Dis 1994; 24: 1.
3. Glicklich D, Tellis VA, Matas AJ, et al. No association between posttransplant erythrocytosis, thromboembolic events and cyclosporin therapy. Transplant Proc 1989; 21: 2121.
4. Innes A, Pal CR, Dennis MJ, Ryan JJ, Morgan AG, Burden RP. Post-transplant erythrocytosis and immunosuppression with cyclosporin: a case-control study. Nephrol Dial Transplant 1991; 6: 588.
5. Pollak R, Maddux MS, Cohan J, Jacobsson PK, Mozes MF. Erythrocythemia following renal transplantation: influence of diuretic therapy. Clin Nephrol 1988; 29: 119.
6. Kay R, Bennett WM, Thorpe J, Barry J. Polycythemia in renal transplant patients. Arch Int Med 1980; 140: 281.
7. Gaston RS, Julian BA, Barker CV, Diethelm AG, Curtis JJ. Enalapril: safe and effective therapy for posttransplant erythrocytosis. Transplant Proc 1993; 25: 1029.
8. Sauron C, Berthoux P, Berthoux F, et al. New insights and treatment in posttransplant polycythemia of renal recipients. Transplant Proc 1993; 25: 1032.
9. Gaston RS, Julian BA, Diethelm AG, Curtis JJ. Effects of enalapril on erythrocytosis after renal transplantation. Ann Intern Med 1991; 115: 954.
10. Danovitch GM, Jamgotchian NJ, Eggena PH, et al. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Transplant 1995; 60: 132.
11. Perzarella M, Mcphedran P, Kliger A, Lorber M, Elliot L, Bia MJ. Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels. Am J Kidney Dis 1995; 26: 495.
12. Wong PC, Hart SD, Zaspel AM, et al. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: Dup 753 (AII-1) and PD 123277 (AII-2). J Pharmacol Exp Ther 1990; 255: 584.
13. Skidgel RA, Erdos EG. Biochemistry of angiotensin converting enzyme. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing, 1993: 10.1-10.10.
14. Yeo WW, Maclean P, Richardson PJ, Ramsey LE. Cough and enalapril: assessment by spontaneous reporting and visual analogue scale under double blind conditions. J Hypertens 1994; 12: 1387.
15. Ducloux D, Bresson-Vautrin C, Chalopin JM. Effects of angiotensin-receptor antagonists on erythrocytosis after renal transplantation [Letter]. Nephrol Dial Transplant 1996; 11(8): 1668.